預防醫學市場：按服務類型、疾病領域、年齡層、交付方式、最終用戶和地區分類

Preventive Medicine Market, By Service Type, By Disease Area, By Age Group, By Mode of Delivery, By End User, By Geography

出版日期: 2025年05月16日 | 出版商:

Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年全球預防保健市場規模為 4.394 億美元，到 2032 年將達到 6.307 億美元，2025 年至 2032 年的複合年成長率為 5.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	4.394億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	5.30%	2032年價值預測	6.307億美元

近年來，隨著人們越來越意識到疾病預防和早期發現的重要性，全球預防性醫療保健市場取得了顯著成長。預防性醫療保健著重於採取積極措施預防疾病發生並促進整體健康和福祉。這種方法涵蓋了廣泛的策略，包括健康體檢、疫苗接種、改變生活方式和風險評估。市場的成長歸因於多種因素，包括慢性病盛行率上升、老年人口成長以及對降低醫療成本的日益重視。此外，診斷工具的技術進步和創新預防療法的開發正在推動市場的擴張。隨著全球各國政府和醫療機構意識到預防性醫療保健的長期益處，預計未來對預防性醫療保健解決方案的需求將保持上升趨勢。

市場動態：

全球預防性醫療保健市場受到多種關鍵促進因素、市場限制因素和市場機會的影響。其中一個關鍵促進因素是心血管疾病、糖尿病和癌症等慢性疾病的盛行率不斷上升。這些疾病的負擔日益加重，導致人們更加重視早期發現和預防，從而刺激了對預防性醫療保健解決方案的需求。此外，全球老年人口的成長進一步推動了市場成長，因為老年人更容易患慢性疾病，需要定期進行預防性醫療保健。然而，預防性醫療保健技術高成本以及某些地區對預防性醫療保健益處的認知較低等因素也限制了市場的發展。

此外，一些國家對預防性醫療保健服務的限制性報銷政策也可能阻礙市場成長。儘管存在這些挑戰，但市場仍提供了巨大的成長和創新機會。穿戴式裝置和遠端醫療等數位醫療技術的日益普及，為遠距監控和個人化預防性醫療保健開闢了新的途徑。此外，基因檢測和生物標記分析等先進診斷工具的開發，使得風險評估和有針對性的預防干涉措施更加準確。隨著各國政府和醫療機構持續重視預防性醫療保健，並向預防性醫療保健計畫投入資源，未來幾年市場可能會大幅成長。

本研究的主要特點

本報告對全球預防性醫療保健市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（百萬美元）和年複合成長率（CAGR%），假設 2024 年為基準年。
它還強調了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球預防性醫療保健市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球預防醫學市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球預防藥物市場的各種策略矩陣來促進他們的決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 439.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.30%	2032 Value Projection:	USD 630.7 Mn

The global preventive medicine market has witnessed significant growth in recent years, driven by the increasing awareness about the importance of disease prevention and early detection. Preventive medicine focuses on the proactive measures taken to prevent the occurrence of diseases and promote overall health and well-being. This approach encompasses a wide range of strategies, including health screenings, vaccinations, lifestyle modifications, and risk assessment. The market's growth can be attributed to several factors, such as the rising prevalence of chronic diseases, the increasing elderly population, and the growing emphasis on reducing healthcare costs. Additionally, technological advancements in diagnostic tools and the development of innovative preventive therapies have further fueled the market's expansion. As governments and healthcare organizations worldwide recognize the long-term benefits of preventive care, the demand for preventive medicine solutions is expected to continue its upward trajectory in the coming years.

Market Dynamic:

The global preventive medicine market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the increasing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and cancer. The rising burden of these diseases has led to a greater emphasis on early detection and prevention, fueling the demand for preventive medicine solutions. Moreover, the growing elderly population worldwide has further accelerated the market's growth, as older individuals are more susceptible to chronic conditions and require regular preventive care. However, the market also faces certain restraints, such as the high costs associated with preventive medicine technologies and the lack of awareness about the benefits of preventive care in some regions.

Additionally, limited reimbursement policies for preventive services in certain countries may hinder the market's growth. Despite these challenges, the market presents significant opportunities for growth and innovation. The increasing adoption of digital health technologies, such as wearable devices and telemedicine, has opened up new avenues for remote monitoring and personalized preventive care. Furthermore, the development of advanced diagnostic tools, such as genetic testing and biomarker analysis, has enabled more accurate risk assessment and targeted preventive interventions. As governments and healthcare organizations continue to prioritize preventive care and allocate resources towards preventive medicine initiatives, the market is poised for substantial growth in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global preventive medicine market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global preventive medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, AstraZeneca, Bayer AG, Becton, Dickinson and Company (BD), bioMerieux, Bristol Myers Squibb, Danaher Corporation, GlaxoSmithKline (GSK), Merck & Co Inc, Novartis, Pfizer, Roche Holding AG, Sanofi, Siemens Healthineers, and Quest Diagnostics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global preventive medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preventive medicine market

Market Segmentation

Service Type Insights
- Screening & Early Detection
- Vaccination & Immunizatio
- Preventive Drug Therapies
- Wellness & Lifestyle Interventions
- Digital Health & Remote Monitoring Services
Disease Area Insights
- Cardiovascular Diseases
- Cancer
- Diabetes
- Infectious Diseases
- Respiratory Diseases
- Mental Health
- Neurological Disorders
- Osteoporosis
- Others
Age Group Insights
- Pediatric
- Adult
- Geriatric
Mode of Delivery Insights
- On-site/In-Person Delivery
- Remote/Virtual Delivery
End User Insights
- Hospitals & Clinics
- Diagnostic Centers
- Government Organizations
- Private Healthcare Providers
- Employers
- Individuals (Self-Care)
Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Abbott Laboratories
- AstraZeneca
- Bayer AG
- Becton, Dickinson and Company (BD)
- bioMerieux
- Bristol Myers Squibb
- Danaher Corporation
- GlaxoSmithKline (GSK)
- Merck & Co Inc
- Novartis
- Pfizer
- Roche Holding AG
- Sanofi
- Siemens Healthineers
- Quest Diagnostics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Preventive Medicine Market, By Service Type
- Global Preventive Medicine Market, By Disease Area
- Global Preventive Medicine Market, By Age Group
- Global Preventive Medicine Market, By Mode of Delivery
- Global Preventive Medicine Market, By End User
- Global Preventive Medicine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Preventive Medicine Market, By Service Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Screening & Early Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Vaccination & Immunization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Preventive Drug Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Wellness & Lifestyle Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Digital Health & Remote Monitoring Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Preventive Medicine Market, By Disease Area, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Respiratory Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Mental Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Osteoporosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Preventive Medicine Market, By Age Group, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Preventive Medicine Market, By Mode of Delivery, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
On-site/In-Person Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Remote/Virtual Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Preventive Medicine Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Government Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Private Healthcare Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Employers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Individuals (Self-Care)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Preventive Medicine Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton, Dickinson and Company (BD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
bioMerieux
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline (GSK)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies